Adrien Briaux

786 total citations
17 papers, 304 citations indexed

About

Adrien Briaux is a scholar working on Oncology, Genetics and Molecular Biology. According to data from OpenAlex, Adrien Briaux has authored 17 papers receiving a total of 304 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 7 papers in Genetics and 6 papers in Molecular Biology. Recurrent topics in Adrien Briaux's work include Genetic factors in colorectal cancer (6 papers), BRCA gene mutations in cancer (5 papers) and Genomic variations and chromosomal abnormalities (3 papers). Adrien Briaux is often cited by papers focused on Genetic factors in colorectal cancer (6 papers), BRCA gene mutations in cancer (5 papers) and Genomic variations and chromosomal abnormalities (3 papers). Adrien Briaux collaborates with scholars based in France, Italy and Spain. Adrien Briaux's co-authors include Ivan Bièche, Rosette Lidereau, Sophie Vacher, Céline Callens, Anne Schnitzler, Leanne de Koning, Véronique Becette, Walid Chemlali, Dominique Stoppa‐Lyonnet and Étienne Rouleau and has published in prestigious journals such as Blood, JNCI Journal of the National Cancer Institute and Scientific Reports.

In The Last Decade

Adrien Briaux

16 papers receiving 300 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Adrien Briaux France 11 146 111 85 78 69 17 304
Petra Zemánková Czechia 10 149 1.0× 106 1.0× 97 1.1× 72 0.9× 117 1.7× 23 308
Zhenjian Cai United States 9 133 0.9× 92 0.8× 39 0.5× 49 0.6× 56 0.8× 26 302
Simona Agata Italy 9 224 1.5× 142 1.3× 79 0.9× 33 0.4× 167 2.4× 12 378
Hirohiko Totsuka Japan 8 195 1.3× 133 1.2× 87 1.0× 35 0.4× 35 0.5× 11 317
Haruko Kunitomi Japan 9 183 1.3× 71 0.6× 112 1.3× 39 0.5× 23 0.3× 17 311
Emily Rayner Netherlands 6 197 1.3× 144 1.3× 176 2.1× 166 2.1× 48 0.7× 8 441
Wanguo Liu United States 7 186 1.3× 80 0.7× 94 1.1× 96 1.2× 159 2.3× 12 368
Mark Barnes United Kingdom 6 198 1.4× 67 0.6× 201 2.4× 51 0.7× 62 0.9× 7 306
Wojciech Kluźniak Poland 12 202 1.4× 161 1.5× 150 1.8× 130 1.7× 297 4.3× 26 482
Patrícia Rocha Portugal 12 179 1.2× 141 1.3× 139 1.6× 116 1.5× 121 1.8× 21 369

Countries citing papers authored by Adrien Briaux

Since Specialization
Citations

This map shows the geographic impact of Adrien Briaux's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adrien Briaux with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adrien Briaux more than expected).

Fields of papers citing papers by Adrien Briaux

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adrien Briaux. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adrien Briaux. The network helps show where Adrien Briaux may publish in the future.

Co-authorship network of co-authors of Adrien Briaux

This figure shows the co-authorship network connecting the top 25 collaborators of Adrien Briaux. A scholar is included among the top collaborators of Adrien Briaux based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adrien Briaux. Adrien Briaux is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
2.
Botty, Rania El, Sophie Vacher, Adrien Briaux, et al.. (2023). HORMAD1 overexpression predicts response to anthracycline–cyclophosphamide and survival in triple‐negative breast cancers. Molecular Oncology. 17(10). 2017–2028. 5 indexed citations
3.
Pinheiro, Hugo, François Cornélis, Didier Meseure, et al.. (2022). The Identification of Large Rearrangements Involving Intron 2 of the CDH1 Gene in BRCA1/2 Negative and Breast Cancer Susceptibility. Genes. 13(12). 2213–2213.
4.
Coussy, Florence, Rania El Botty, Laetitia Fuhrmann, et al.. (2020). Combination of PI3K and MEK inhibitors yields durable remission in PDX models of PIK3CA-mutated metaplastic breast cancers. Journal of Hematology & Oncology. 13(1). 13–13. 43 indexed citations
5.
Lallemand, François, Sophie Vacher, Leanne de Koning, et al.. (2020). The high protein expression of FOXO3, but not that of FOXO1, is associated with markers of good prognosis. Scientific Reports. 10(1). 6920–6920. 6 indexed citations
6.
Cacheux, Wulfran, Astrid Lièvre, Sophie Richon, et al.. (2019). Interaction between IGF2‐PI3K axis and cancer‐associated‐fibroblasts promotes anal squamous carcinogenesis. International Journal of Cancer. 145(7). 1852–1859. 20 indexed citations
7.
Grellety, Thomas, Céline Callens, Élodie Richard, et al.. (2018). Enhancing Abiraterone Acetate Efficacy in Androgen Receptor–positive Triple-negative Breast Cancer: Chk1 as a Potential Target. Clinical Cancer Research. 25(2). 856–867. 19 indexed citations
8.
Xu, Liang, Adrien Briaux, Véronique Becette, et al.. (2018). Molecular profiling of hormone receptor-positive, HER2-negative breast cancers from patients treated with neoadjuvant endocrine therapy in the CARMINA 02 trial (UCBG-0609). Journal of Hematology & Oncology. 11(1). 124–124. 23 indexed citations
9.
Vargaftig, Jacques, H. Farhat, Lionel Adès, et al.. (2018). Phase 2 Trial of Single Agent Gedatolisib (PF-05212384), a Dual PI3K/mTOR Inhibitor, for Adverse Prognosis and Relapse/Refractory AML: Clinical and Transcriptomic Results. Blood. 132(Supplement 1). 5233–5233. 8 indexed citations
10.
Cacheux, Wulfran, Petros Tsantoulis, Adrien Briaux, et al.. (2018). Array comparative genomic hybridization identifies high level of PI3K/Akt/mTOR pathway alterations in anal cancer recurrences. Cancer Medicine. 7(7). 3213–3225. 9 indexed citations
11.
Caputo, Sandrine M., Laurent Castéra, Adrien Briaux, et al.. (2017). Assessment of the functional impact of germline BRCA1/2 variants located in non-coding regions in families with breast and/or ovarian cancer predisposition. Breast Cancer Research and Treatment. 168(2). 311–325. 13 indexed citations
12.
Mouret‐Fourme, Emmanuelle, Adrien Briaux, Véronique Becette, et al.. (2017). Risk of Serous Endometrial Carcinoma in Women With Pathogenic BRCA1/2 Variant After Risk-Reducing Salpingo-Oophorectomy. JNCI Journal of the National Cancer Institute. 110(2). 213–215. 31 indexed citations
13.
Cacheux, Wulfran, Virginie Dangles-Marie, Étienne Rouleau, et al.. (2017). Exome sequencing reveals aberrant signalling pathways as hallmark of treatment-naive anal squamous cell carcinoma. Oncotarget. 9(1). 464–476. 19 indexed citations
14.
Rondeau, Sophie, Sophie Vacher, Leanne de Koning, et al.. (2015). ATM has a major role in the double-strand break repair pathway dysregulation in sporadic breast carcinomas and is an independent prognostic marker at both mRNA and protein levels. British Journal of Cancer. 112(6). 1059–1066. 44 indexed citations
15.
Cheeseman, Kevin, Étienne Rouleau, Anne Vannier, et al.. (2012). A diagnostic genetic test for the physical mapping of germline rearrangements in the susceptibility breast cancer genes BRCA1 and BRCA2. Human Mutation. 33(6). 998–1009. 15 indexed citations
16.
Rouleau, Étienne, Hélène Zattara, Cédrick Lefol, et al.. (2011). First large rearrangement in the MUTYH gene and attenuated familial adenomatous polyposis syndrome. Clinical Genetics. 80(3). 301–303. 12 indexed citations
17.
Lagarde, Arnaud, Etienne Rouleau, Anthony Ferrari, et al.. (2010). Germline APC mutation spectrum derived from 863 genomic variations identified through a 15-year medical genetics service to French patients with FAP: Figure 1. Journal of Medical Genetics. 47(10). 721–722. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Petra Zemánková Breakdown of academic impact, for papers by Zhenjian Cai Breakdown of academic impact, for papers by Simona Agata Breakdown of academic impact, for papers by Hirohiko Totsuka Breakdown of academic impact, for papers by Haruko Kunitomi Breakdown of academic impact, for papers by Emily Rayner Breakdown of academic impact, for papers by Wanguo Liu Breakdown of academic impact, for papers by Mark Barnes Breakdown of academic impact, for papers by Wojciech Kluźniak Breakdown of academic impact, for papers by Patrícia Rocha
Rankless by CCL
2026